- Pros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesGoyvaerts Cleo; Breckpot KarineJournal of Immunology Research, 2015, 785634.
- Toward a new stage of PD-1 blockade cancer immunotherapyNagahiro, MinatoInternational Journal of Clinical Oncology, 2020, 25(5): 787-789.被引 3
- Blockade of PD-L1 interaction with CD80 in trans augments anti-tumor immunity by increasing NOS2 in tumor-associated macrophages.Zhang, Yuankun; Song, Qingxiao; Lee, Michael; Tang, Haidong; Cassady, Kaniel; Fu, Yang-Xin; Schones, Dustin E.; Riggs, Arthur; Feng, Ru; Zeng, DefuAnnual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA, 2021-04-10 To 2021.
期刊论文
Targeting the tumor microenvironment to enhance antitumor immune responses
13阅读
